Seòmar agus comataidhean

The Fireworks and Pyrotechnic Articles (Scotland) Act 2022 was passed by the Scottish Parliament in June of this year and received Royal Assent on 10 August.

Work is underway to implement the measures within the Act. Firework licensing, Part 2 of the Act, requires secondary legislation and the development of an appropriate licensing system as part of implementation. The licensing system will therefore not be in place until late 2023/early 2024 at the earliest.

Since the Level of Service Case Management Inventory (LS/CMI) IT errors were identified three forms of review have been underway:

• Open cases review
• Risk Management Authority review
• IT review

Letters have been submitted to the Criminal Justice Committee on 3 March 2022, 12 May 2022, 28 June 2022, and 27 September 2022, providing updates on these three review elements.

The Risk Management Authority review is not looking at “failed assessments”. They are exploring impact from the known system error in relation to risk and scoring. Part of that review is an assessment of possible material impact, as it is a feature of risk assessment that much more than one IT system output goes into the risk assessment process.

With the caveat that the review work has to be led by what is found at each phase, it is currently anticipated that phase 3 of this work will conclude in November 2022 and report thereafter.

Scottish Ministers are committed to developing a Scottish school milk scheme to replace current subsidy arrangements. We are working with stakeholders and local authority partners to develop a fully funded universal school milk scheme for primary and special schools, and a pilot in secondary schools within the current parliamentary term.

Data showing the percentage of pre-registration students who were in the "inactive" training state on a three-year pre-registration midwifery programme over the last five years for which complete figures are available is found in the table below. “Inactive” refers to students who are neither in training nor have completed their programme – many students will return to their studies and go on to complete their programme.

The Scottish Government has awarded the Scottish Council on Global Affairs (SCGA) grant funding of £120,295.17 for the financial year 2022-2023.

We will continue to support the SCGA as they develop throughout 2022-2023, and look forward to seeing the SCGA provide a Scotland-based, independent, and non-partisan forum for meaningful debate on international affairs.

Public Health Scotland (PHS) receives monthly data from most NHS Boards on the number of patients covered by the 18 weeks Referral to Treatment (RTT) standard seen within each specialty, including audiology. Due to the aggregate nature of this data collection, the requested detail on average length of wait and age are not available.

However, Table 1 shows the total number of patients seen and the number that waited over 18 weeks to be seen for audiology services across NHS Scotland, from January 2014 to December 2021 – the latest complete calendar year. This includes all patients reported as seen on the 18-week RTT pathway for audiology. Please note, almost all patients on this pathway are not admitted for treatment and their journey ends after seeing an audiologist in an outpatient setting.

Due to the complexities of 18 week RTT local data collection and reporting, the length of wait cannot be accurately measured by the Board of treatment for all patients. The impact of which for audiology is reflected in the number of unknown waits reported in the following table.

Table 1: Total patients seen and number of patients that waited over 18 weeks, January 2014 – December 2021, NHS Scotland, Audiology.

In Scotland, the Scottish Medicines Consortium (SMC) appraises the clinical and cost-effectiveness of newly-licensed medicines. Following a full submission for zanubrutinib (Brukinsa ® ) as monotherapy for the treatment of adult patients with Waldenström’s macroglobulinaemia (WM) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy, the SMC issued ‘not recommended’ advice for routine use of this medicine in NHS Scotland on 12 September 2022. The advice detailed that a comparable drug is currently available for this indication, and the company did not present a sufficiently robust economic analysis to gain acceptance by the SMC.

However, the SMC has received a fast track resubmission which was reviewed at the SMC’s Committee meeting on 4 October 2022, and its advice will be published on 7 November 2022. In the meantime, you can access a summary of the current status of this resubmission on the SMC’s website here .

There are alternative routes of access available for a medicine that is not recommended by the SMC. A doctor can request access to licensed medicines for a patient on an individual ‘case-by-case’ basis through the Peer Approved Clinical System (PACS) Tier Two process, where a doctor considers there would be a clinical benefit for a patient.

The decision on whether to prescribe a medicine for a patient, and which medicine to prescribe, is entirely one for the clinician in charge of a patient’s care to make, having taken into account the patient’s clinical condition and the safety of the patient.

As set out in our public consultation we are considering how to address health inequalities and promote equitable access to cancer services. We have outlined ‘reducing inequalities’ as one of our main aims in the consultation. With over 250 responses received we have now commissioned independent analysis of the responses and anticipate the results to be published shortly. The results will inform the cancer strategy.

In addition, we held a series of workshops with patients and key stakeholders in September 2022 to help us gain further insight into the consultation responses and hear directly about peoples’ experiences of cancer and inform the development of the cancer strategy.

The final Union Connectivity Review (UCR) Report was published in November 2021.

In March 2022, Transport Scotland officials had discussions with their UK Government counterparts at the Department for Transport (DfT) at which the findings of the UCR were discussed. Transport Scotland also provided an update on the second Strategic Transport Projects Review (STPR2) which had been published in January 2022, in particular Recommendation 40, which relates to the A75 and A77.

Discussions have continued on the subject of possible related funding opportunities for development work on the A75 and the next scheduled meeting between officials is on 31 October.

Measures to combat crimes of this nature are an operational matter for Police Scotland.

Since 2012-13, crimes of dishonesty, which includes theft of a motor vehicle, theft from a motor vehicle and a number of other kinds of theft and dishonesty have reduced by 32%. However, that should not detract from the seriousness of these incidents when they do occur.

Supporting Police Scotland to keep our communities safe remains a priority for the Scottish Government. Policing services have been maintained and improved and we have invested over £10 billion in policing since the creation of the single service in 2013.

We will continue supporting the vital work of Police Scotland in delivering effective and responsive policing across Scotland.